Listen Now
Topics Covered
- Overview & Definition of Diagnostic Technologies & Biomarkers in the Context of COVID-19
- How Diagnostic Technologies & Biomarkers Shape & Improve Treatment Decisions
- Why the Molecular Portrait of Cancer is Important
- The Role of the Pathologist
- Benefits of Diagnostic Technologies, Biomarkers & Precision Medicine
- Predicting Response to Treatment
- Clinical Trials: How Research Contributes to Your Treatment Options
- Key Questions to Ask Your Health Care Team
- Guidelines for Preparing for Telehealth Appointments with Your Health Care Team, including Technology, Prepared List of Questions, Quality-of-Life Concerns & Discussion of 2021 Care’s Act
- Questions for Our Panel of Experts
Our Panel of Experts
Mark G. Kris, MD
William and Joy Ruane Chair in Thoracic Oncology, Attending Physician, Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Professor of Medicine, Weill Cornell Medical College
Michael J. Mauro, MD
Leader, Myeloproliferative Neoplasms Program, Member, Memorial Sloan Kettering Cancer Center, Professor, Weill Cornell Medicine
Tanios Bekaii-Saab, MD, FACP
Leader, Gastrointestinal Cancer Program, Mayo Clinic Cancer Center, Professor, Mayo Clinic College of Medicine and Science, Consultant, Mayo Clinic in Arizona
Sarah E. Kerr, MD
Pathologist, Divisions of Cytopathology, Pulmonary, Gynecologic, and Molecular Pathology, Hospital Pathology Associates, P. A., Allina Health Laboratory, Allina Health Cancer Institute
Monika Franco, PhD
Policy Analyst, Public Policy & Advocacy, Association for Molecular Pathology
Carolyn Messner, DSW, BCD, FAPOS, FAOSW
Senior Director of Education and Training, CancerCare
Brochure
You can download the brochure for this workshop
Workshop Date
This workshop was originally recorded on January 23, 2023.